Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer: A Prospective Study Based on Data from a Swedish Population-Based Cohort

Aus, GunnarDepartment of Urology, Sahlgrens University Hospital, 413 45, Göteborg, Sweden (författare)

Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer : A Prospective Study Based on Data from a Swedish Population-Based Cohort

Objective: At presentation of prostate cancer, patients with proven lymph node metastasis (N1) are comparatively rare. It is difficult to give prognostic information based on the present literature. The aim of this study was to evaluate the impact of known risk factors in patients with pelvic node involvement and without distant metastasis. Methods: From the population-based, prospective prostate cancer tumour registry of the South–East Region in Sweden, we collected data on all 181 patients with N1, M0 prostate cancer diagnosed from January 1987 to October 2000 with a follow-up to December 2001. Mean follow-up was 62 months. Pre-operative risk factors as age, T-category, serum PSA, tumour grade and also primary treatment given was correlated to the outcome. Results: Median age at diagnosis was 65 years. Cancer-specific survival was highly variable with 5-year survival of 72%, a median of 8 years and the projected 13-year figure was 31%. T-category, age, PSA or treatment did not affect the outcome while poorly differentiated tumours had a tendency towards lower cancer-specific survival (p=0.0523) when compared to well and moderately differentiated tumours. Conclusions: This population-based cohort of prostate cancer patients with pelvic node involvement treated principally with non-curative intent had a median cancer-specific survival of 8 years. Preoperatively known risk factors seem to have but a modest impact on the prognosis for patients in this stage of the disease.

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
Prostate cancer; Lymph node metastasis; N-category; Prognosis; Risk factors; Treatment
Oncology
Onkologi
MEDICINE
MEDICIN

Nordenskjöld, KerstinLinköpings universitet,Institutionen för klinisk och experimentell medicin,Hälsouniversitetet (författare)
Robinson, DavidDepartment of Surgery, Höglandssjukhuset, Eksjö, Sweden (författare)
Rosell, JohanÖstergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US(Swepub:liu)johro19 (författare)
Varenhorst, EberhardDepartment of Urology and Surgery, Vrinnevisjukhuset, Norrköping, Sweden(Swepub:liu)ebeva05 (författare)
Department of Urology, Sahlgrens University Hospital, 413 45, Göteborg, SwedenInstitutionen för klinisk och experimentell medicin (creator_code:org_t)

Av författaren/redakt...: Aus, Gunnar; Nordenskjöld, Ke ...; Robinson, David; Rosell, Johan; Varenhorst, Eber ...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.